DK0565965T3 - Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf - Google Patents

Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0565965T3
DK0565965T3 DK93105441.5T DK93105441T DK0565965T3 DK 0565965 T3 DK0565965 T3 DK 0565965T3 DK 93105441 T DK93105441 T DK 93105441T DK 0565965 T3 DK0565965 T3 DK 0565965T3
Authority
DK
Denmark
Prior art keywords
benzo
protecting
thiophen
formula
optically active
Prior art date
Application number
DK93105441.5T
Other languages
English (en)
Inventor
Tetsuo Yamafuji
Hisaaki Chaki
Joji Nakano
Nobuhisa Taya
Kaishu Momonoi
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK0565965T3 publication Critical patent/DK0565965T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Seasonings (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
DK93105441.5T 1992-04-13 1993-04-01 Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf DK0565965T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11974092 1992-04-13
JP5090934A JP2873898B2 (ja) 1992-04-13 1993-03-25 ベンゾ[b]チオフェン−5−イル誘導体もしくはその光学活性体またはそれらの塩並びにそれらの製造法

Publications (1)

Publication Number Publication Date
DK0565965T3 true DK0565965T3 (da) 1997-04-21

Family

ID=26432339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93105441.5T DK0565965T3 (da) 1992-04-13 1993-04-01 Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf

Country Status (19)

Country Link
US (1) US5380878A (da)
EP (1) EP0565965B1 (da)
JP (1) JP2873898B2 (da)
KR (1) KR960005955B1 (da)
AT (1) ATE145204T1 (da)
AU (1) AU643634B1 (da)
BE (1) BE1006403A3 (da)
CA (1) CA2093048C (da)
CZ (2) CZ290421B6 (da)
DE (1) DE69305904T2 (da)
DK (1) DK0565965T3 (da)
ES (1) ES2060545B1 (da)
FR (1) FR2689890B1 (da)
HU (1) HU213631B (da)
IT (1) IT1261440B (da)
NZ (1) NZ247301A (da)
PL (1) PL172191B1 (da)
RO (1) RO115445B1 (da)
TW (1) TW232690B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606076A (en) * 1995-06-07 1997-02-25 Eli Lilly And Company Process for the synthesis of benzo[b]thiophenes
AU2576797A (en) * 1996-04-22 1997-11-12 Toyama Chemical Co. Ltd. Patch containing 1,2-ethanediol derivatives or salts thereof
JP4245668B2 (ja) * 1997-03-31 2009-03-25 富山化学工業株式会社 2−(ベンゾ〔b〕チオフェン−5−イル)−2−ヒドロキシ酢酸誘導体もしくはその光学活性体またはそれらの塩の製造法
AU770234B2 (en) * 1999-06-11 2004-02-19 Toyama Chemical Co. Ltd. N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof and agents for treating neurodegenerative diseases comprising the same
KR100710564B1 (ko) * 2003-07-30 2007-04-24 에스케이 주식회사 연속 모사 이동층 흡착분리공정을 이용한 광학활성티오펜계 화합물의 분리방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500147A (da) * 1979-11-15 1982-01-28
DE3582995D1 (de) * 1984-10-25 1991-07-04 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
DK167393B1 (da) * 1985-12-30 1993-10-25 Roussel Uclaf 1-sulfonyl-2-oxo-pyrrolidinderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
IT1204494B (it) * 1986-03-28 1989-03-01 Roussel Maestretti Spa Derivati della 1-stirene solfonil 2-osso 5-alcossi pirrolidina,loro procedimento di preparazione e loro applicazione come farmaci
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
JPH0813741B2 (ja) * 1987-08-10 1996-02-14 協和醗酵工業株式会社 抗痴呆剤
US4877790A (en) * 1987-12-15 1989-10-31 Kanebo Limited Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
US4859666A (en) * 1988-07-06 1989-08-22 Bristol-Myers Company THAZ derivatives for enhancement of cerebral function
JPH085790B2 (ja) * 1988-11-11 1996-01-24 杏林製薬株式会社 記憶障害改善薬
NZ232493A (en) * 1989-02-14 1992-06-25 Toyama Chemical Co Ltd Aryl- or heterocyclyl-substituted 1,2-ethanediol derivatives and pharmaceutical compositions
JP3044055B2 (ja) * 1990-08-09 2000-05-22 富山化学工業株式会社 1,2―エタンジオール誘導体およびその塩

Also Published As

Publication number Publication date
CZ290864B6 (cs) 2002-11-13
FR2689890B1 (fr) 1995-01-06
CA2093048A1 (en) 1993-10-14
HUT64319A (en) 1993-12-28
EP0565965A2 (en) 1993-10-20
CA2093048C (en) 1996-10-08
EP0565965A3 (da) 1994-03-02
EP0565965B1 (en) 1996-11-13
PL172191B1 (pl) 1997-08-29
TW232690B (da) 1994-10-21
ITRM930232A1 (it) 1994-10-09
JPH069615A (ja) 1994-01-18
US5380878A (en) 1995-01-10
ES2060545B1 (es) 1997-12-01
AU643634B1 (en) 1993-11-18
FR2689890A1 (fr) 1993-10-15
KR960005955B1 (ko) 1996-05-06
IT1261440B (it) 1996-05-23
ATE145204T1 (de) 1996-11-15
BE1006403A3 (fr) 1994-08-16
CZ61093A3 (en) 1993-12-15
HU213631B (en) 1997-08-28
ES2060545A1 (es) 1994-11-16
DE69305904D1 (de) 1996-12-19
NZ247301A (en) 1994-07-26
PL298494A1 (en) 1993-12-27
RO115445B1 (ro) 2000-02-28
KR930021632A (ko) 1993-11-22
HU9301052D0 (en) 1993-07-28
JP2873898B2 (ja) 1999-03-24
CZ290421B6 (cs) 2002-07-17
ITRM930232A0 (it) 1993-04-09
DE69305904T2 (de) 1997-03-13

Similar Documents

Publication Publication Date Title
FI951593A0 (fi) Uusi menetelmä bakkatiini-III:n ja 10-desasetyylibakkatiini-III:n esteröimiseksi
RU95110686A (ru) Способ получения производных таксана, промежуточные соединения для их синтеза
FI880742A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, 7-asemassa substituoitujen 19-norsteroidien valmistamiseksi
KR920006358A (ko) 1-메틸카르바펜엠 유도체 및 그의 제조방법
IT1261440B (it) Derivato di benzo b tiofen-5-ile e procedimento per la sua produzione.
KR890016061A (ko) 펩티드 유도체
ES477791A1 (es) Un procedimiento para preparar derivados de acido acetico.
DK470181A (da) Fremgangsmaade til fremstilling af beta-lactamer
KR850004754A (ko) 3-인돌 카르복사미드 화합물류의 제조방법
NO174848C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte
FI102679B1 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjohdannaisten valmistamiseksi
ES2147196T3 (es) Procedimiento para la hidrolisis estereoespecifica de derivados de piperidindiona.
ES8704480A1 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidropiridina.
UY24697A1 (es) Metodos para producir inhibidores de vih-proteasa y productos intermedios para producir inhibidores de vih-proteasa
PT87219A (pt) Process for preparing sulfonyldecahydro-8h-isoquino ]2,1-g" ]1,6" naphthyridines optical isomers thereof and related compounds
KR960017669A (ko) 양쪽성 3환식 화합물
FI940999A0 (fi) Piperidin-2-alkyylikarboksylaattien entsymaattinen toisiintuminen ja saatujen yhdisteiden käyttö synteesin välituotteina
FR2609603B1 (fr) Agents edulcorants derives des acides guanidinoacetique et ethanamidinoacetique, procede pour edulcorer des produits divers, et compositions contenant de tels agents edulcorants
DE69123009D1 (de) Verfahren zur Herstellung optisch aktiver 3-Hydroxybutan-Derivate
SE8901060D0 (sv) New compounds
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
ATE384706T1 (de) Verfahren zur kontinuierlichen herstellung von substituierten oxazolen
DE3675424D1 (de) Valiolaminderivate und ihre herstellung.
DE69123402D1 (de) Verfahren zur Herstellung optisch aktiver Alpha-Hydroxyalkenderivate
KR920002564A (ko) N-알킬 티아졸리딘 유도체